Rocket Lab’s sales jumped 55% year-on-year to $104.8 million in the third quarter, a performance that sent its stock close to ...

Rocket Lab USA (RKLB – Research Report), the Industrials sector company, was revisited by a Wall Street analyst today. Analyst Ronald ...

Stifel analyst Erik Rasmussen increased his price target on Rocket Lab stock by more than 50% on Friday. Rasmussen is encouraged by progress on Rocket Lab's new Neutron rocketship. The analyst ...

Rocket Lab (NASDAQ: RKLB) stock rocketed 11.2% through noon ET Monday after investment bank Stifel raised its price target on Friday. Reports indicate that Stifel analyst Erik Rasmussen raised his ...

Stifel (SF, Financial) analysts have updated their price estimates, giving Rocket Lab (RKLB, Financial) a higher value of $15 than its previous projection of $9.This update followed the Stifel ...

Rocket Lab is scheduled to report third-quarter financial results after the market close on Tuesday. Analysts expect the company to report a loss of 11 cents per share and revenue of $102.28 million.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) yesterday and set a price target of $49.00. The company’s shares closed yesterday at ...

Rocket Lab’s share price has surged to its highest level since November 2021. It has soared by over 320% from its lowest level this year. The company will publish its financial results on Tuesday.